Renal Transplant clinical trials

Explore recruiting renal transplant clinical trials.

Recruiting renal transplant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Renal Transplant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months. EPURE TRANSPLANT

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PRODIG : Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early post-transplant period

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MCA-derived MSC therapy in renal transplant recipients

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Blockade of the renin-angiotensin system in kidney transplant patients with the presence of renal progenitor cells in urine: randomized clinical trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Netherlands, Spain, Germany, Belgium, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Renal Transplant trials by city

Renal Transplant in Toronto Renal Transplant in Vancouver Renal Transplant in Montreal Renal Transplant in Calgary Renal Transplant in Edmonton Renal Transplant in Ottawa Renal Transplant in Winnipeg Renal Transplant in Quebec City Renal Transplant in Hamilton Renal Transplant in Kitchener Renal Transplant in London Renal Transplant in Halifax Renal Transplant in New York Renal Transplant in Los Angeles Renal Transplant in Chicago Renal Transplant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease